Successful Use of Surgically Placed Impella 5.0 and Central Extracorporeal Membrane Oxygenation Circuit in a Patient with Postcardiotomy Shock

The Impella 5.0, a percutaneously inserted left ventricular assist device, has been used to support patients who have severe heart failure or who are undergoing high-risk percutaneous coronary intervention. We report our surgical placement of the Impella 5.0, through a graft sewn to the aorta, to unload the left ventricle of a 59-year-old man who was undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy shock. The patient underwent successful placement of a long-term left ventricular assist device before his discharge from the hospital. The versatility of the Impella 5.0 is exemplified in this patient who was successfully bridged to long-term support.     

Design and preliminary results of FRENSHOCK 2016: A prospective nationwide multicentre registry on cardiogenic shock

Central illustration: geographic distribution of the 49 centres participating in the FRENSHOCK registry (35 academic hospitals, 10 general hospitals and four private clinics). Inclusion per centre varied from 1 to 72 patients.

     

依达拉奉联合瑞舒伐他汀治疗心源性脑梗死的疗效及对血清CXCL12、UCH-L1、HC-gp39水平的影响

目的 探究依达拉奉联合瑞舒伐他汀治疗心源性脑梗死的疗效及对血清趋化因子12（CXCL12）、泛素C末端水解酶L1（UCH-L1）、人类软骨糖蛋白-39（HC-gp39）水平的影响。方法 选取2020年3月—2022年4月达州市中心医院收治的90例心源性脑梗死患者作为研究对象,随机分为对照组和观察组,各45例。对照组给予瑞舒伐他汀治疗,观察组给予依达拉奉联合瑞舒伐他汀治疗。比较两组疗效、CXCL12、UCH-L1、HC-gp39、血液流变学指标、血脂水平及美国国立卫生研究院脑卒中量表（NIHSS）评分。结果 观察组总有效率高于对照组（P <0.05）。观察组治疗前后血清CXCL12、UCH-L1、HC-gp39水平的差值高于对照组（P <0.05）。观察组治疗前后全血低切黏度、全血高切黏度及纤维蛋白原水平的差值高于对照组（P <0.05）。观察组治疗前后TC、TG、LDL-C水平的差值高于对照组（P <0.05）。观察组治疗前后NIHSS评分的差值高于对照组（P <0.05）。结论 依达拉奉联合瑞舒伐他汀治疗心源性心肌梗死可有效提高患者临床疗效,改善血液流变学指标、血脂、神经功能及炎症反应。     

救心复脉注射液治疗心源性休克的临床研究

验证救心复脉注射液治疗心源性休克的临床疗效。方法：用ＣＡ静脉给药治疗心源性休克２０例，用多巴胺注射液作对照。结果；ＣＡ组有效１８例，无效２例，ＤＡ组有效９例，无效２例，组间比较，Ｐ〉０．０５。结论ＣＡ和ＤＡ均能升高血压，增加心泵功能，改善厥脱证的症脉，但ＣＡ比ＤＡ升压速度快，幅度高，作用稳定，对心率有双相调节作用，使心动过速患者心率减慢，使心动过缓患者心率增快。     

参附青注射液对休克大鼠血压、心脏血液动力学和肠系膜微循环的影响

采用内毒素休克和心源性休克大鼠模型，观察参附青注射液对血压、心肌收缩力、肠系膜微循环的影响。结果表明，该方对内毒素休克大鼠上述指标有明显改善，而仅改变心源性休克大鼠的微循环     

参附青注射液对休克大鼠血压、心脏血液动力学和肠系膜微循环的影响

采用内毒素休克和心源性休克大鼠模型，观察参附青注射液对血压、心肌收缩力、肠系膜微循环的影响。结果表明，该方对内毒素休克大鼠上述指标有明显改善而仅改变心源性休克大鼠的微循环。